ZLAB Zai Lab Ltd

NEUTRAL Impact: 3/10 144
Horizon immediate Filed Apr 6, 2026 Processed 2mo ago SEC 0001959173-26-002783
Form 144 — notice of proposed sale of securities
Latest settled — T+5d ⚠ clustered
ZLAB ▲ +4.10% at T+5d
NEUTRAL call ✓ call won +4.10% · α vs SPY -0.04% · entry $20.50 → $21.34
Next anchor: T+20d due 6w ago
Currently $17.07 · -16.73% from $20.50 entry
Entry anchored
Apr 6, 03:03 PM ET
via Databento tick
T+1d
+2.44%
call +2.44% · α +2.38%
$21.00
settled 2mo ago
T+5d
+4.10%
call +4.10% · α -0.04%
$21.34
settled 2mo ago
T+20d
call — · α —
due 6w ago
T+60d
call — · α —
in 18d

Price Chart

Loading chart...

Executive Summary

Yajing Chen, an officer of Zai Lab Ltd, filed a Form 144 to report the proposed sale of 853 American Depositary Shares (ADSs), valued at approximately $174,426, following the vesting of restricted stock. The sale is intended to cover tax obligations related to the vesting event.

Actionable Insight

This Form 144 reflects a standard tax-related sale following equity vesting and is not a signal of negative sentiment. Traders should monitor for any follow-on discretionary sales beyond tax settlements.

Key Facts

  • Yajing Chen, an officer of Zai Lab, intends to sell 853 ADSs valued at $174,426.
  • The sale follows the vesting of restricted stock on April 2, 2026, and is intended to cover tax obligations.
  • This is a routine transaction tied to equity compensation settlement, not a discretionary sale.
  • Recent insider activity includes four sell transactions totaling $590K in the past 30 days.
  • Zai Lab’s market cap is $2.3B; this transaction represents a negligible portion of shares outstanding.

Financial Impact

Approximately $174,426 in shares to be sold to cover tax liabilities from equity vesting.

insider ownershipshare count outstanding (minor)

Risk Factors

  • Perception of insider selling, though contextually routine and non-discretionary.
  • Accumulation of small insider sales could signal broader sentiment if trend continues.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-002783
Document: 0001959173-26-002783-index.html0001959173-26-002783
Document: 0001959173-26-002783.txt0001959173-26-002783
14 reports for ZLAB
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ZLAB — sortable, filterable
Type Now
Jun 11, 2026
1d ago
Institutional Cluster
BEARISH ★ 5/10
$17.66 awaiting T+5awaiting T+5$17.07 (+3.31%)
May 21, 2026
22d ago
8-K
NEUTRAL ★ 4/10
$18.61 $17.09▼ −8.17%▼ −9.83%$17.07 (−8.28%)
May 19, 2026
24d ago
Insider Cluster
NEUTRAL ★ 3/10
$18.81 $18.69▼ −0.64%▼ −1.88%$17.07 (−9.25%)
May 19, 2026
24d ago
Insider Cluster
BEARISH ★ 6/10
$18.81 $18.69▲ +0.64%▲ +1.88%$17.07 (+9.25%)
May 7, 2026
5w ago
8-K
BEARISH ★ 6/10
$19.77 $20.47▼ −3.57%▼ −2.06%$17.07 (+13.64%)
Apr 28, 2026
6w ago
DEFA14A
NEUTRAL ★ 2/10
$22.14 $20.98▼ −5.24%▼ −6.93%$17.07 (−22.90%)
Apr 6, 2026
9w ago
144
NEUTRAL ★ 3/10
$20.50 $21.34▲ +4.10%▼ −0.04%$17.07 (−16.73%)
Apr 6, 2026
9w ago
144
NEUTRAL ★ 3/10
$20.50 $21.34▲ +4.10%▼ −0.04%$17.07 (−16.73%)
Mar 11, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$19.47 awaiting T+5awaiting T+5$17.07 (+12.30%)
Mar 5, 2026
14w ago
Insider Cluster
NEUTRAL ★ 4/10
$19.30 awaiting T+5awaiting T+5$17.07 (−11.55%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (46h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access